Cancer timing and site revealed distinct antibody and smoking associations in systemic sclerosis. Discover what the EUSTAR ...
Erratum: Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With BRAFV600-Mutant Metastatic Non–Small-Cell Lung Cancer Risk Factors for Primary Bone Cancer After Childhood Cancer: ...
CA-125 KELIM as a Potential Complementary Tool for Predicting Veliparib Benefit: An Exploratory Analysis From the VELIA/GOG-3005 Study This study includes the PanCareSurFup and ProCardio cohort of ≥ 5 ...
Investigators conducted a nested case-control study of women aged ≥ 40 years from the general population of Sweden for the years 2009-2019. Analyses assessed menopausal hormone therapy use among 943 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results